Stryker Corporation
$ 307.80
2.21%
18 Jun - close price
- Market Cap 117,998,436,000 USD
- Current Price $ 307.80
- High / Low $ 311.54 / 299.36
- Stock P/E 35.67
- Book Value 58.61
- EPS 8.63
- Next Earning Report 2026-07-30
- Dividend Per Share $3.44
- Dividend Yield 1.14 %
- Next Dividend Date 2026-07-31
- ROA 0.08 %
- ROE 0.15 %
- 52 Week High 401.86
- 52 Week Low 281.00
About
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Analyst Target Price
$386.80
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-01-29 | 2025-10-30 | 2025-07-31 | 2025-05-01 | 2025-01-28 | 2024-10-29 | 2024-07-30 | 2024-04-30 | 2024-01-30 | 2023-11-02 | 2023-08-03 |
| Reported EPS | 2.6 | 4.47 | 3.19 | 3.13 | 2.84 | 4.01 | 2.87 | 2.81 | 2.5 | 3.46 | 2.46 | 2.54 |
| Estimated EPS | 2.98 | 4.4 | 3.13 | 3.07 | 2.73 | 3.87 | 2.77 | 2.79 | 2.36 | 3.27 | 2.44 | 2.38 |
| Surprise | -0.38 | 0.07 | 0.06 | 0.06 | 0.11 | 0.14 | 0.1 | 0.02 | 0.14 | 0.19 | 0.02 | 0.16 |
| Surprise Percentage | -12.7517% | 1.5909% | 1.9169% | 1.9544% | 4.0293% | 3.6176% | 3.6101% | 0.7168% | 5.9322% | 5.8104% | 0.8197% | 6.7227% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 3.49 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-30 | 2026-01-30 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 |
| Amount | $0.88 | $0.88 | $0.84 | $0.84 | $0.84 | $0.84 | $0.8 | $0.8 | $0.8 | $0.8 |
Next Dividend Records
| Dividend per share (year): | $3.44 |
| Dividend Yield | 1.14% |
| Next Dividend Date | 2026-07-31 |
| Ex-Dividend Date | 2026-06-30 |
Recent News: SYK
2026-06-19 19:41:04
Treace Medical Concepts (TMCI) reported Q3 2024 revenue of $45.1 million, an 11% increase year-over-year, and a net loss of $15.4 million ($0.25 per share), an improvement from the prior year. The company launched the Nanoplasty 3D MIS system and is pursuing patent litigation. TMCI revised its full-year 2024 revenue guidance to $204–$211 million and aims for Adjusted EBITDA break-even in 2025.
2026-06-19 16:34:57
This article examines three US dividend growth stocks—Abbott Laboratories (ABT), Stryker (SYK), and Masco (MAS)—in the context of higher short-term bond yields at 4.0%. It highlights how these rates influence investor focus on steady income, balance sheet strength, and payout discipline. The piece analyzes each company's financial health, growth prospects, and dividend track record, suggesting that while they offer potential, investors must carefully weigh pros and cons like debt levels and growth forecasts against current market conditions.
2026-06-19 07:38:52
Jefferies has reiterated its Buy rating for Stryker Corp (SYK.US) but has reduced the target price for the company's stock to $455. This adjustment reflects an updated outlook while still maintaining a positive stance on the company's investment potential.
2026-06-19 05:11:07
This page provides news and event updates for Zimmer Biomet (ZBH), including dividend declarations, stock buyback plans, and earnings analysis. Recent news highlights point to the company's increased stock buyback target of up to $1 billion in 2026 and positive Q1 2026 earnings, alongside market commentary on stock performance. The Intellectia AI platform presents this information as part of its AI investing insights.
2026-06-18 20:10:13
Tandem Diabetes Care Inc (TNDM) has an earnings forecast score of 7.33, ranking 142nd in its industry. Analysts have a consensus "Buy" rating with an average price target of $18.00 and an expected upside of 74.22%. The company's next quarter revenue is projected at $255.18 million, and EPS is expected to be -$0.33.
2026-06-18 18:15:30
Stryker Corp (SYK) saw its stock rise by 3.03% due to a federal court ruling in its favor regarding a patent infringement dispute, the launch of new surgical products, and expanded adoption of its Mako robotic system. The company's strong performance is supported by robust demand for elective procedures, providing revenue visibility for the latter half of the fiscal year despite earlier cyber disruption challenges. Institutional trading activity further bolstered investor confidence.
